Andy Gillespie

Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa.

Richard L. Heideman, Diane E. Cole, Frank M. Balis et al. · PubMed · 1989 · 143 citations

Thrombosis, Dose-dependent Plasma Clearance, Tt Dose +14

Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

Jenna M. Kahn, Andy Gillespie, Maria Tsokos et al. · Frontiers in Oncology · 2014 · 138 citations · Full text

Phase I Clinical Trial of Intrathecal Topotecan in Patients With Neoplastic Meningitis

Susan M. Blaney, Richard L. Heideman, Stacey L. Berg et al. · Journal of Clinical Oncology · 2002 · 98 citations

Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.

Susan M. Blaney, Michael N. Needle, Andy Gillespie et al. · PubMed · 1998 · 63 citations

Neuro-oncology, Radiation Therapy, Refractory Neuroblastoma +15

Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.

Stacey L. Berg, Frank M. Balis, Solomon Zimm et al. · Journal of Clinical Oncology · 1992 · 61 citations